EX-23.1 2 ex23-1.htm CONSENT

 

GSK plc 11-K

 

Exhibit 23.1 

 

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

 

We consent to the incorporation by reference to Registration Statement No. 333-235651 and 333- 162702 of GlaxoSmithKline PLC on Form S-8 of our report dated June 12, 2023, relating to the financial statements and supplemental schedule of the GSK Puerto Rico 401(k) Plan, appearing in this Annual Report on Form 11-K of the GSK Puerto Rico 401(k) Plan for the year ended December 31, 2022.

 

 

 

Philadelphia, Pennsylvania 

June 12, 2023